Beyfortus (Nirsevimab-alip) Injection 50 mg/mL Prefilled Syringe, 0.5 mL, 5/Package
Beyfortus (nirsevimab-alip) is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal antibody indicated for the prevention of RSV lower respiratory tract disease in neonates and infants. This formulation is supplied as a 50 mg/mL solution in a 0.5 mL prefilled syringe, packaged as 5 syringes per package. Administered as a single intramuscular injection.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Beyfortus (nirsevimab-alip) is a respiratory syncytial virus (RSV) F protein inhibitor monoclonal antibody indicated for the prevention of RSV lower respiratory tract disease in neonates and infants. This formulation is supplied as a 50 mg/mL solution in a 0.5 mL prefilled syringe, packaged as 5 syringes per package. Administered as a single intramuscular injection.
1 vendor
